Beacon Financial Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-533
| Closed | -$258K | – | 370 |
|
|
2025
Q1 | $258K | Buy |
+533
| New | +$258K | 0.08% | 268 |
|
|
2024
Q4 | – | Sell |
-446
| Closed | -$207K | – | 313 |
|
|
2024
Q3 | $207K | Buy |
446
+12
| +3% | +$5.58K | 0.07% | 276 |
|
|
2024
Q2 | $203K | Buy |
+434
| New | +$203K | 0.08% | 272 |
|
|
2024
Q1 | – | Sell |
-512
| Closed | -$208K | – | 279 |
|
|
2023
Q4 | $208K | Buy |
+512
| New | +$208K | 0.1% | 234 |
|